APO Research, Inc.

APO RESEARCH · REPORT

Lidocaine Transdermal Patch

Selected research

Industry Growth & Trends

Global Lidocaine Transdermal Patch Industry Growth and Trends Forecast to 2032

Market perspective

The global Lidocaine Transdermal Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lidocaine Transdermal Patch include Teva Pharmaceutical, Tide Pharmaceutical (SINO BIOPHARM), Mylan, Teikoku, Sorrento Therapeutics, Par Pharmaceutical, Hisamitsu and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lidocaine Transdermal Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lidocaine Transdermal Patch market size, estimates, and forecasts are presented in terms of sales volume (m pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lidocaine Transdermal Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lidocaine Transdermal Patch.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lidocaine Transdermal Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lidocaine Transdermal Patch Market by Company

Teva Pharmaceutical

Tide Pharmaceutical (SINO BIOPHARM)

Mylan

Teikoku

Sorrento Therapeutics

Par Pharmaceutical

Hisamitsu

Endo International

Lidocaine Transdermal Patch Segment by Type

Lidocare 1.80% Transdermal Patch

Lidocare 5% Transdermal Patch

Lidocare 4% Transdermal Patch

Lidocaine Transdermal Patch Segment by Application

Clinic

Hospital Pharmacies

Online Pharmacies

Chain Pharmacies

Monomer Pharmacies

Other

Lidocaine Transdermal Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Transdermal Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lidocaine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lidocare 1.80% Transdermal Patch Table 2. Major Company of Lidocare 5% Transdermal Patch Table 3. Major Company of Lidocare 4% Transdermal Patch Table 4. Global Lidocaine Transdermal Patch Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lidocaine Transdermal Patch Sales by Type (2021-2026) & (m pcs) Table 6. Global Lidocaine Transdermal Patch Sales Market Share in Volume by Type (2021-2026) Table 7. Global Lidocaine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 8. Global Lidocaine Transdermal Patch Sales Market Share in Value by Type (2021-2026) Table 9. Global Lidocaine Transdermal Patch Price by Type (2021-2026) & (US$/k pcs) Table 10. Global Lidocaine Transdermal Patch Sales by Type (2027-2032) & (m pcs) Table 11. Global Lidocaine Transdermal Patch Sales Market Share in Volume by Type (2027-2032) Table 12. Global Lidocaine Transdermal Patch Sales by Type (2027-2032) & (US$ Million) Table 13. Global Lidocaine Transdermal Patch Sales Market Share in Value by Type (2027-2032) Table 14. Global Lidocaine Transdermal Patch Price by Type (2027-2032) & (US$/k pcs) Table 15. North America Lidocaine Transdermal Patch Sales by Type (2021-2026) & (m pcs) Table 16. North America Lidocaine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Lidocaine Transdermal Patch Sales by Type (2021-2026) & (m pcs) Table 18. Europe Lidocaine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Lidocaine Transdermal Patch Sales by Type (2021-2026) & (m pcs) Table 20. Asia-Pacific Lidocaine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Lidocaine Transdermal Patch Sales by Type (2021-2026) & (m pcs) Table 22. Latin America Lidocaine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Lidocaine Transdermal Patch Sales by Type (2021-2026) & (m pcs) Table 24. Middle East and Africa Lidocaine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 25. Lidocaine Transdermal Patch Industry Trends Table 26. Lidocaine Transdermal Patch Industry Drivers Table 27. Lidocaine Transdermal Patch Industry Opportunities and Challenges Table 28. Lidocaine Transdermal Patch Industry Restraints Table 29. Global Lidocaine Transdermal Patch Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Lidocaine Transdermal Patch Revenue Market Share by Company (2021-2026) Table 31. Global Lidocaine Transdermal Patch Sales by Company (2021-2026) & (m pcs) Table 32. Global Lidocaine Transdermal Patch Sales Share by Company (2021-2026) Table 33. Global Lidocaine Transdermal Patch Market Price by Company (2021-2026) & (US$/k pcs) Table 34. Global Lidocaine Transdermal Patch Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Lidocaine Transdermal Patch Major Company Production Sites and Headquarters Table 36. Global Lidocaine Transdermal Patch Company, Product Type & Application Table 37. Global Lidocaine Transdermal Patch Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Lidocaine Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Lidocaine Transdermal Patch Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Lidocaine Transdermal Patch Sales by Region (2021-2026) & (m pcs) Table 42. Global Lidocaine Transdermal Patch Sales Market Share in Volume by Region (2021-2026) Table 43. Global Lidocaine Transdermal Patch Sales by Region (2021-2026) & (US$ Million) Table 44. Global Lidocaine Transdermal Patch Sales Market Share in Value by Region (2021-2026) Table 45. Global Lidocaine Transdermal Patch Sales (m pcs), Value (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 46. Global Lidocaine Transdermal Patch Sales by Region (2027-2032) & (m pcs) Table 47. Global Lidocaine Transdermal Patch Sales Market Share in Volume by Region (2027-2032) Table 48. Global Lidocaine Transdermal Patch Sales by Region (2027-2032) & (US$ Million) Table 49. Global Lidocaine Transdermal Patch Sales Market Share in Value by Region (2027-2032) Table 50. Global Lidocaine Transdermal Patch Sales (m pcs), Value (US$ Million), Price (US$/k pcs) and Gross Margin (2027-2032) Table 51. Global Lidocaine Transdermal Patch Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Lidocaine Transdermal Patch Sales by Application (2021-2026) & (m pcs) Table 53. Global Lidocaine Transdermal Patch Sales Market Share in Volume by Application (2021-2026) Table 54. Global Lidocaine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 55. Global Lidocaine Transdermal Patch Sales Market Share in Value by Application (2021-2026) Table 56. Global Lidocaine Transdermal Patch Price by Application (2021-2026) & (US$/k pcs) Table 57. Global Lidocaine Transdermal Patch Sales by Application (2027-2032) & (m pcs) Table 58. Global Lidocaine Transdermal Patch Sales Market Share in Volume by Application (2027-2032) Table 59. Global Lidocaine Transdermal Patch Sales by Application (2027-2032) & (US$ Million) Table 60. Global Lidocaine Transdermal Patch Sales Market Share in Value by Application (2027-2032) Table 61. Global Lidocaine Transdermal Patch Price by Application (2027-2032) & (US$/k pcs) Table 62. North America Lidocaine Transdermal Patch Sales by Application (2021-2026) & (m pcs) Table 63. North America Lidocaine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Lidocaine Transdermal Patch Sales by Application (2021-2026) & (m pcs) Table 65. Europe Lidocaine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Lidocaine Transdermal Patch Sales by Application (2021-2026) & (m pcs) Table 67. Asia-Pacific Lidocaine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Lidocaine Transdermal Patch Sales by Application (2021-2026) & (m pcs) Table 69. Latin America Lidocaine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Lidocaine Transdermal Patch Sales by Application (2021-2026) & (m pcs) Table 71. Middle East and Africa Lidocaine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Company Information Table 73. Teva Pharmaceutical Business Overview Table 74. Teva Pharmaceutical Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio Table 76. Teva Pharmaceutical Recent Development Table 77. Tide Pharmaceutical (SINO BIOPHARM) Company Information Table 78. Tide Pharmaceutical (SINO BIOPHARM) Business Overview Table 79. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 80. Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio Table 81. Tide Pharmaceutical (SINO BIOPHARM) Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 85. Mylan Lidocaine Transdermal Patch Product Portfolio Table 86. Mylan Recent Development Table 87. Teikoku Company Information Table 88. Teikoku Business Overview Table 89. Teikoku Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 90. Teikoku Lidocaine Transdermal Patch Product Portfolio Table 91. Teikoku Recent Development Table 92. Sorrento Therapeutics Company Information Table 93. Sorrento Therapeutics Business Overview Table 94. Sorrento Therapeutics Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 95. Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio Table 96. Sorrento Therapeutics Recent Development Table 97. Par Pharmaceutical Company Information Table 98. Par Pharmaceutical Business Overview Table 99. Par Pharmaceutical Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 100. Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio Table 101. Par Pharmaceutical Recent Development Table 102. Hisamitsu Company Information Table 103. Hisamitsu Business Overview Table 104. Hisamitsu Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 105. Hisamitsu Lidocaine Transdermal Patch Product Portfolio Table 106. Hisamitsu Recent Development Table 107. Endo International Company Information Table 108. Endo International Business Overview Table 109. Endo International Lidocaine Transdermal Patch Sales (m pcs), Revenue (US$ Million), Price (US$/k pcs) and Gross Margin (2021-2026) Table 110. Endo International Lidocaine Transdermal Patch Product Portfolio Table 111. Endo International Recent Development Table 112. North America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (m pcs): 2021 VS 2025 VS 2032 Table 113. North America Lidocaine Transdermal Patch Sales by Country (2021-2026) & (m pcs) Table 114. North America Lidocaine Transdermal Patch Sales Market Share by Country (2021-2026) Table 115. North America Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032) & (m pcs) Table 116. North America Lidocaine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 117. North America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Lidocaine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Lidocaine Transdermal Patch Market Share by Country (2021-2026) Table 120. North America Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Lidocaine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 122. Europe Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (m pcs): 2021 VS 2025 VS 2032 Table 123. Europe Lidocaine Transdermal Patch Sales by Country (2021-2026) & (m pcs) Table 124. Europe Lidocaine Transdermal Patch Sales Market Share by Country (2021-2026) Table 125. Europe Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032) & (m pcs) Table 126. Europe Lidocaine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Lidocaine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Lidocaine Transdermal Patch Market Share by Country (2021-2026) Table 130. Europe Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Lidocaine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (m pcs): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Lidocaine Transdermal Patch Sales by Country (2021-2026) & (m pcs) Table 134. Asia-Pacific Lidocaine Transdermal Patch Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032) & (m pcs) Table 136. Asia-Pacific Lidocaine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Lidocaine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Lidocaine Transdermal Patch Market Share by Country (2021-2026) Table 140. Asia-Pacific Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Lidocaine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 142. Latin America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (m pcs): 2021 VS 2025 VS 2032 Table 143. Latin America Lidocaine Transdermal Patch Sales by Country (2021-2026) & (m pcs) Table 144. Latin America Lidocaine Transdermal Patch Sales Market Share by Country (2021-2026) Table 145. Latin America Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032) & (m pcs) Table 146. Latin America Lidocaine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Lidocaine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Lidocaine Transdermal Patch Market Share by Country (2021-2026) Table 150. Latin America Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Lidocaine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (m pcs): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2021-2026) & (m pcs) Table 154. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032) & (m pcs) Table 156. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Lidocaine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Lidocaine Transdermal Patch Market Share by Country (2021-2026) Table 160. Middle East and Africa Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Lidocaine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Lidocaine Transdermal Patch Distributors List Table 165. Lidocaine Transdermal Patch Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Lidocaine Transdermal Patch Image Figure 2. Global Lidocaine Transdermal Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lidocaine Transdermal Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Lidocaine Transdermal Patch Sales (2021-2032) & (m pcs) Figure 5. Lidocare 1.80% Transdermal Patch Image Figure 6. Global Lidocare 1.80% Transdermal Patch Sales YoY Growth (2021-2032) & (m pcs) Figure 7. Lidocare 5% Transdermal Patch Image Figure 8. Global Lidocare 5% Transdermal Patch Sales YoY Growth (2021-2032) & (m pcs) Figure 9. Lidocare 4% Transdermal Patch Image Figure 10. Global Lidocare 4% Transdermal Patch Sales YoY Growth (2021-2032) & (m pcs) Figure 11. Global Lidocaine Transdermal Patch Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Lidocaine Transdermal Patch Market Share by Type 2025 VS 2032 Figure 13. North America Lidocaine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 14. North America Lidocaine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 15. Europe Lidocaine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 16. Europe Lidocaine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Lidocaine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Lidocaine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 19. Latin America Lidocaine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Lidocaine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Lidocaine Transdermal Patch Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (m pcs) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (m pcs) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (m pcs) Figure 31. Chain Pharmacies Image Figure 32. Global Chain Pharmacies Sales YoY Growth (2021-2032) & (m pcs) Figure 33. Monomer Pharmacies Image Figure 34. Global Monomer Pharmacies Sales YoY Growth (2021-2032) & (m pcs) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (m pcs) Figure 37. Global Lidocaine Transdermal Patch Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Lidocaine Transdermal Patch Market Share by Application 2025 VS 2032 Figure 39. North America Lidocaine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 40. North America Lidocaine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 41. Europe Lidocaine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 42. Europe Lidocaine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Lidocaine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Lidocaine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 45. Latin America Lidocaine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Lidocaine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Lidocaine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 49. North America Lidocaine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (m pcs) Figure 50. North America Lidocaine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Lidocaine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Lidocaine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (m pcs) Figure 54. Europe Lidocaine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Lidocaine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Lidocaine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (m pcs) Figure 58. Asia-Pacific Lidocaine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Lidocaine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Lidocaine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (m pcs) Figure 62. Latin America Lidocaine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Lidocaine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Lidocaine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (m pcs) Figure 66. Middle East and Africa Lidocaine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Lidocaine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Lidocaine Transdermal Patch Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Lidocaine Transdermal Patch Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Lidocare 1.80% Transdermal Patch
  • Lidocare 5% Transdermal Patch
  • Lidocare 4% Transdermal Patch
Applications
  • Clinic
  • Hospital Pharmacies
  • Online Pharmacies
  • Chain Pharmacies
  • Monomer Pharmacies
  • Other
Companies covered
  • Teva Pharmaceutical
  • Tide Pharmaceutical (SINO BIOPHARM)
  • Mylan
  • Teikoku
  • Sorrento Therapeutics
  • Par Pharmaceutical
  • Hisamitsu
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lidocaine Transdermal Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lidocaine Transdermal Patch Market by Type
  6. 1.3.1 Lidocare 1.80% Transdermal Patch
  7. 1.3.2 Lidocare 5% Transdermal Patch
  8. 1.3.3 Lidocare 4% Transdermal Patch
  9. 1.4 Global Lidocaine Transdermal Patch Market Size by Type
  10. 1.4.1 Global Lidocaine Transdermal Patch Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Lidocaine Transdermal Patch Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lidocaine Transdermal Patch Industry Trends
  2. 2.2 Lidocaine Transdermal Patch Industry Drivers
  3. 2.3 Lidocaine Transdermal Patch Industry Opportunities and Challenges
  4. 2.4 Lidocaine Transdermal Patch Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lidocaine Transdermal Patch Revenue (2021-2026)
  2. 3.2 Global Top Players by Lidocaine Transdermal Patch Sales (2021-2026)
  3. 3.3 Global Top Players by Lidocaine Transdermal Patch Price (2021-2026)
  4. 3.4 Global Lidocaine Transdermal Patch Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lidocaine Transdermal Patch Major Company Production Sites & Headquarters
  6. 3.6 Global Lidocaine Transdermal Patch Company, Product Type & Application
  7. 3.7 Global Lidocaine Transdermal Patch Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lidocaine Transdermal Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lidocaine Transdermal Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lidocaine Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Lidocaine Transdermal Patch Regional Status and Outlook
  1. 4.1 Global Lidocaine Transdermal Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lidocaine Transdermal Patch Historic Market Size by Region
  3. 4.2.1 Global Lidocaine Transdermal Patch Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lidocaine Transdermal Patch Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lidocaine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Region
  7. 4.3.1 Global Lidocaine Transdermal Patch Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lidocaine Transdermal Patch Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lidocaine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lidocaine Transdermal Patch by Application
  1. 5.1 Lidocaine Transdermal Patch Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Chain Pharmacies
  6. 5.1.5 Monomer Pharmacies
  7. 5.1.6 Other
  8. 5.2 Global Lidocaine Transdermal Patch Market Size by Application
  9. 5.2.1 Global Lidocaine Transdermal Patch Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Lidocaine Transdermal Patch Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Tide Pharmaceutical (SINO BIOPHARM)
  8. 6.2.1 Tide Pharmaceutical (SINO BIOPHARM) Company Information
  9. 6.2.2 Tide Pharmaceutical (SINO BIOPHARM) Business Overview
  10. 6.2.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio
  12. 6.2.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Lidocaine Transdermal Patch Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Teikoku
  20. 6.4.1 Teikoku Company Information
  21. 6.4.2 Teikoku Business Overview
  22. 6.4.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teikoku Lidocaine Transdermal Patch Product Portfolio
  24. 6.4.5 Teikoku Recent Developments
  25. 6.5 Sorrento Therapeutics
  26. 6.5.1 Sorrento Therapeutics Company Information
  27. 6.5.2 Sorrento Therapeutics Business Overview
  28. 6.5.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio
  30. 6.5.5 Sorrento Therapeutics Recent Developments
  31. 6.6 Par Pharmaceutical
  32. 6.6.1 Par Pharmaceutical Company Information
  33. 6.6.2 Par Pharmaceutical Business Overview
  34. 6.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
  36. 6.6.5 Par Pharmaceutical Recent Developments
  37. 6.7 Hisamitsu
  38. 6.7.1 Hisamitsu Company Information
  39. 6.7.2 Hisamitsu Business Overview
  40. 6.7.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hisamitsu Lidocaine Transdermal Patch Product Portfolio
  42. 6.7.5 Hisamitsu Recent Developments
  43. 6.8 Endo International
  44. 6.8.1 Endo International Company Information
  45. 6.8.2 Endo International Business Overview
  46. 6.8.3 Endo International Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Endo International Lidocaine Transdermal Patch Product Portfolio
  48. 6.8.5 Endo International Recent Developments
7 North America by Country
  1. 7.1 North America Lidocaine Transdermal Patch Sales by Country
  2. 7.1.1 North America Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lidocaine Transdermal Patch Sales by Country (2021-2026)
  4. 7.1.3 North America Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lidocaine Transdermal Patch Market Size by Country
  6. 7.2.1 North America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lidocaine Transdermal Patch Market Size by Country (2021-2026)
  8. 7.2.3 North America Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lidocaine Transdermal Patch Sales by Country
  2. 8.1.1 Europe Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lidocaine Transdermal Patch Sales by Country (2021-2026)
  4. 8.1.3 Europe Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lidocaine Transdermal Patch Market Size by Country
  6. 8.2.1 Europe Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lidocaine Transdermal Patch Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lidocaine Transdermal Patch Sales by Country
  2. 9.1.1 Asia-Pacific Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lidocaine Transdermal Patch Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lidocaine Transdermal Patch Market Size by Country
  6. 9.2.1 Asia-Pacific Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lidocaine Transdermal Patch Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lidocaine Transdermal Patch Sales by Country
  2. 10.1.1 South America Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lidocaine Transdermal Patch Sales by Country (2021-2026)
  4. 10.1.3 South America Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lidocaine Transdermal Patch Market Size by Country
  6. 10.2.1 South America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lidocaine Transdermal Patch Market Size by Country (2021-2026)
  8. 10.2.3 South America Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lidocaine Transdermal Patch Sales by Country
  2. 11.1.1 Middle East and Africa Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country
  6. 11.2.1 Middle East and Africa Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lidocaine Transdermal Patch Value Chain Analysis
  2. 12.1.1 Lidocaine Transdermal Patch Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lidocaine Transdermal Patch Production Mode & Process
  7. 12.2 Lidocaine Transdermal Patch Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lidocaine Transdermal Patch Distributors
  10. 12.2.3 Lidocaine Transdermal Patch Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.